Twitxy Saved

Malte Roerden

@RoerdenM

Physician-scientist interested in cancer immunology and immunotherapy | University Hospital Tübingen | @MIT alumni
Tübingen, Germany roerdenlab.com Joined October 2019
367 Following 163 Followers 85 Posts

Latest posts 5

Malte Roerden @RoerdenM
Support our fight against Multiple Sclerosis!

We are raising funds to advance our research and bring CAR-T cell therapy—an innovative and promising treatment—into a clinical trial.

To support our mission, share this post or donate here:
hommage-tuebingen.de
www.hommage-tuebingen.de Hommage | Förderverein Innere Medizin II am UKT | Otfried-Müller-Straße 10, Tübingen, Germany HOMMAGE der Förderverein Innere Medizin II am Universitätsklinikum Tübingen e.V. Wir fördern Forschung und Pflege
Malte Roerden @RoerdenM
Very excited to share our recent work now published in @NatRevImmunol!
We reviewed how immune evasion mechanisms interfere with immunoediting to fosters intratumor heterogeneity (ITH) and discuss data on the role of ITH itself in blunting anti-tumor immunity.
@stefanispranger
Cancer immune evasion, immunoediting and intratumour heterogeneity go.nature.com/3BPBMoc
View quoted post on X
Malte Roerden @RoerdenM
Thank you @jitcancer for the nice summary of our latest project where we studied how different neoantigen expression patterns impact anti-tumor immunity 👇
Here’s a closer look at #JITC article: “Neoantigen architectures define immunogenicity and drive immune evasion of tumors with heterogenous neoantigen expression” by authors @RoerdenM @stefanispranger from @kochinstitute 1/11
View quoted post on X
Malte Roerden @RoerdenM
Our latest paper is now out in #JITC! Modeling different NeoAg architectures, we found that these define the immunogenicity of tumor branches and uncover how they mediate immune evasion. Our findings may inform target prioritization for cancer vaccines. See link below!
Journal for ImmunoTherapy of Cancer Verified account @jitcancer Nov 9, 2024
New #JITC article: Neoantigen architectures define immunogenicity and drive immune evasion of tumors with heterogenous neoantigen expression bit.ly/4ejyxSZ @RoerdenM @kevlitchfield @stefanispranger #SITC24
View quoted post on X